IRVINE, CALIF., January 6, 2025 – BioDuro, a leading Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that its sites in Jiangsu and the Shanghai Free Trade Zone (FTZ) in China have each been awarded a Gold Medal in the 2024 EcoVadis business sustainability assessment, placing them among the top 3% and 5% of the companies it has evaluated in the last 12 months, respectively. These achievements underscore BioDuro’s dedication to sustainability and its proactive approach to integrating environmental and social responsibility into its business strategies and operations.
“Achieving the EcoVadis Gold Rating highlights BioDuro’s exceptional performance in the themes of environmental stewardship, ethics, labor and human rights, and sustainable procurement,” said Dr. Armin Spura, CEO of BioDuro. “With nearly three decades of success in the CDMO industry, we remain steadfast in upholding the highest standards of compliance and quality as we work to create enduring value for our employees, suppliers, clients, and society.”
The Gold-rated Jiangsu and Shanghai FTZ sites are an integral part of BioDuro’s global CRDMO network. Each leverages its broad expertise in biology, drug metabolism and pharmacokinetics (DMPK), and chemistry to offer comprehensive and integrated drug discovery services, spanning from target to hit, hit to lead, until preclinical compound selection. The Jiangsu site also provides advanced oral dosage pre-formulation, formulation development, and manufacturing services, and the site in the Shanghai FTZ has recently launched a compound management center, enhancing its operational efficiency.
About EcoVadis
EcoVadis is a purpose-driven company dedicated to embedding sustainability intelligence into every business decision worldwide. We offer a full range of solutions including IQ-Plus Risk & Compliance Management, EcoVadis Ratings, and Carbon Action Module for Scope 3 Decarbonization. Key features like 360/Live News Monitoring, Academy E-learning and Corrective action plans help companies comply with ESG regulations, reduce GHG emissions, and improve the sustainability performance of their business and value chain across 250 industries in 185 countries.
About BioDuro
BioDuro, an Advent International portfolio company, is a CRDMO with a 29-year proven track record. Headquartered in Irvine, California, USA, our global presence spans 7 sites across the United States and China, with over 2,000 employees. Specializing in both small and large molecule discovery, development, scale-up, and manufacturing, we offer fully integrated services from early drug discovery to commercial manufacturing across chemistry, biology, DMPK, drug substance, and drug product.
Home